Białecki Piotr, Bohatyrewicz Andrzej, Machoy-Mokrzyńska Anna, Białecka Monika
Katedra i Klinika Ortopedii i Traumatologii, Pomorska Akademia Medyczna w Szczecinie.
Chir Narzadow Ruchu Ortop Pol. 2008 Jul-Aug;73(4):266-73.
The bisphosphonates (BP) are well established as the treatment of choice for disorders of excessive bone resorption. Their classical pharmacological effects appear to result from two key properties: affinity for bone mineral and inhibitory effects on osteoclasts. Presented paper contains overview of the most important information concerning application of bisphosphonates in orthopedics. This compilation has been extended and includes also cellular mechanisms of action, pharmacological classification as well as adverse effects of this drugs' group. The most significant differences between the various individual BP and basic pharmacokinetic properties have been shown. This manuscript presents clinical guidelines on safe bisphosphonates usage.
双膦酸盐(BP)已被公认为是治疗骨吸收过多疾病的首选药物。它们的经典药理作用似乎源于两个关键特性:对骨矿物质的亲和力和对破骨细胞的抑制作用。本文概述了双膦酸盐在骨科应用中最重要的信息。这一汇编内容有所扩充,还包括其细胞作用机制、药理分类以及该类药物的不良反应。文中展示了各种双膦酸盐之间最显著的差异以及基本的药代动力学特性。本手稿提出了双膦酸盐安全使用的临床指南。